CHIARINI, FRANCESCA

CHIARINI, FRANCESCA  

DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE  

Personale esterno ed autonomi  

Mostra records
Risultati 1 - 20 di 40 (tempo di esecuzione: 0.031 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES Buontempo, Francesca; Orsini, E; Cappellini, Alessandra; Lonetti, Annalisa; Evangelisti, C; Chiar...ini, Francesca; Spartà, Am; Bressanin, D; Evangelisti, C; Martelli, Am 2014-01-01 HAEMATOLOGICA - 4.02 Riassunto (Abstract) -
A role of PI-PLCb1 in G1/S transition in human erythroleukemia k562 cells Alessandro Poli; Irene Faenza; Alessandro Matteucci; Francesca Chiarini; Lucio Cocco 2012-01-01 - - 4.03 Poster -
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235, against T-cell acute lymphoblastic leukemia. F. Chiarini; C. Grimaldi; F. Ricci; P. L. Tazzari; C.Evangelisti; A. Ognibene; M.Battistelli; E. ...Falcieri; F. Melchionda; A. Pession; P. Pagliaro; J.A. McCubrey; A.M. Martelli. 2010-01-01 CANCER RESEARCH - 1.01 Articolo in rivista -
Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy McCubrey J.A.; Sokolosky M.L.; Lehmann B.D.; Taylor J.R.; Navolanic P.M.; Chappell W.H.; Abrams S....L.; Stadelman K.M.; Wong E.W.; Misaghian N.; Horn S.; Bäsecke J.; Libra M.; Stivala F.; Ligresti G.; Tafuri A.; Milella M.; Zarzycki M.; Dzugaj A.; Chiarini F.; Evangelisti C.; Martelli A.M.; Terrian D.M.; Franklin R.A.; Steelman L.S. 2008-01-01 - Elsevier Ltd. 2.01 Capitolo / saggio in libro -
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. Grimaldi C.; Chiarini F.; Tabellini G.; Ricci F.; Tazzari P.L.; Battistelli M.; Falcieri E.; Bort...ul R.; Melchionda F.; Iacobucci I.; Pagliaro P.; Martinelli G.; Pession A.; Barata J.T.; McCubrey J.A.; Martelli A.M. 2012-01-01 LEUKEMIA - 1.01 Articolo in rivista -
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance Bortolotti, Sonia; Angelucci, Silvia; Montemurro, Luca; Bartolucci, Damiano; Raieli, Salvatore; L...ampis, Silvia; Amadesi, Camilla; Scardovi, Annalisa; Nieddu, Giammario; Cerisoli, Lucia; Paganelli, Francesca; Chiarini, Francesca; Teti, Gabriella; Falconi, Mirella; Pession, Andrea; Hrelia, Patrizia; Tonelli, Roberto 2023-01-01 CANCERS - 1.01 Articolo in rivista cancers-15-00990.pdf
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS Evangelisti, C; Evangelisti, C; Teti, G; Falconi, M; Cappellini, A; Chiarini, F; Buontempo, F; Br...essanin, D; Lonetti, A; Spartà, A; Bittman, R; Pyne, S; Pyne, N; Martelli, Am 2014-01-01 HAEMATOLOGICA - 4.02 Riassunto (Abstract) -
Assessment of the structural and functional characteristics of human mesenchymal stem cells associated with a prolonged exposure of morphine Carano F.; Teti G.; Ruggeri A.; Chiarini F.; Giorgetti A.; Mazzotti M.C.; Fais P.; Falconi M. 2021-01-01 SCIENTIFIC REPORTS - 1.01 Articolo in rivista 41598_2021_Article_98682.pdf41598_2021_98682_MOESM1_ESM.pdf
Cellular senescence in vascular wall mesenchymal stromal cells, a possible contribution to the development of aortic aneurysm Teti G.; Chiarini F.; Mazzotti E.; Ruggeri A.; Carano F.; Falconi M. 2021-01-01 MECHANISMS OF AGEING AND DEVELOPMENT - 1.01 Articolo in rivista 1-s2.0-S0047637421000877-main.pdf1-s2.0-S0047637421000877-mmc1.docx
Dual inhibition of class IA phoshatidylinositol 3-kinase and mTOR as a new therapeutic option for T-cell acute lymphoblastic leukemia. F. Chiarini; F. Falà; P. L. Tazzari; F. Ricci; A. Astolfi; A. Pession; P. Pagliaro; J.A. McCubrey...; A.M. Martelli. 2009-01-01 CANCER RESEARCH - 1.01 Articolo in rivista -
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients. Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Francesca Chiarini; Stefania Paolini; Michele B...accarani; Giovanni Martinelli; Lucia Manzoli; Alberto M. Martelli; Carlo Finelli; Lucio Cocco 2009-01-01 BLOOD - 4.01 Contributo in Atti di convegno -
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients Matilde Y Follo; Cristina Clissa; Sara Mongiorgi; Francesca Chiarini; Michele Baccarani; Giovanni... Martinelli; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco 2011-01-01 BLOOD - 4.01 Contributo in Atti di convegno -
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. A.M. Martelli; V. Papa; P.L. Tazzari; F. Ricci; C. Evangelisti; F. Chiarini; C. Grimaldi; A. Capp...ellini; G. Martinelli; E. Ottaviani; P. Pagliaro; S. Horn; J. Bäsecke; L.H. Lindner; H. Eibl; J.A. McCubrey. 2010-01-01 LEUKEMIA - 1.01 Articolo in rivista -
Inhibition of methyltransferase dot1l sensitizes to sorafenib treatment aml cells irrespective of mll-rearrangements: A novel therapeutic strategy for pediatric aml Lonetti A.; Indio V.; Laginestra M.A.; Tarantino G.; Chiarini F.; Astolfi A.; Bertuccio S.N.; Mar...telli A.M.; Locatelli F.; Pession A.; Masetti R. 2020-01-01 CANCERS - 1.01 Articolo in rivista cancers-12-01972.pdfcancers-12-01972-s001.zip
Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression. Fiume R; Ramazzotti G; Teti G; Chiarini F; Faenza I; Mazzotti G; Billi AM;
Cocco L
2009-01-01 THE FASEB JOURNAL - 1.01 Articolo in rivista -
Lamin A acts a tumor suppressor in Ewing sarcoma promoting neural differentiation and reducing cell migration and invasion Chiarini F, Balestra T, Fazio A, Paganelli F, Maltarello MC, Evangelisti C, Capanni C, Petrini S,... Martelli AM, Lattanzi G, Scotlandi K 2019-01-01 - - 4.03 Poster -
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells Camilla Evangelisti, Francesca Paganelli, Gaia Giuntini, Elisabetta Mattioli, Alessandra Cappelli...ni, Giulia Ramazzotti, Irene Faenza, Maria Cristina Maltarello, Alberto M. Martelli, Katia Scotlandi, Francesca Chiarini, Giovanna Lattanzi 2020-01-01 CELLS - 1.01 Articolo in rivista cells-09-00774.pdfcells-09-00774-s001.zip
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. Annalisa Lonetti, Alessandra Cappellini, Antonino Maria Spartà, Francesca Chiarini, Francesca Buo...ntempo, Camilla Evangelisti, Cecilia Evangelisti, Ester Orsini, James A. McCubrey, Alberto Maria Martelli 2015-01-01 ONCOTARGET - 1.01 Articolo in rivista PI3K pan inhibition impairs more efficiently proliferation and survival of T cell acute lymphoblastic leukemia cell lines when compared to isoform selective PI3K inhibitors..pdf
Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia Evangelisti C; Ricci F; Tazzari P; Chiarini F; Battistelli M; Falcieri E;
Ognibene A; Pagliaro P;...
Cocco L; McCubrey JA; Martelli AM
2011-01-01 JOURNAL OF CELLULAR PHYSIOLOGY - 1.01 Articolo in rivista -
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia. Falà F; Blalock WL; Tazzari PL; Cappellini A; Chiarini F; Martinelli G; Tafuri A; McCubrey JA; Co...cco L; Martelli AM 2008-01-01 MOLECULAR PHARMACOLOGY - 1.01 Articolo in rivista -